DeDora Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$32.1K Buy
+514
New +$32.5K 0.01% 212
2023
Q3
– Sell
-3,381
Closed -$216K – 100
2023
Q2
$216K Buy
3,381
+4
+0.1% +$268 0.08% 98
2023
Q1
$234K Sell
3,377
-338
-9% -$23.8K 0.1% 98
2022
Q4
$267K Buy
3,715
+3
+0.1% +$226 0.13% 95
2022
Q3
$264K Sell
3,712
-104
-3% -$7.54K 0.14% 89
2022
Q2
$294K Sell
3,816
-106
-3% -$8.07K 0.15% 83
2022
Q1
$286K Buy
+3,922
New +$263K 0.12% 85
2021
Q4
– Sell
-4,621
Closed -$273K – 65
2021
Q3
$273K Sell
4,621
-27
-0.6% -$1.78K 0.12% 84
2021
Q2
$311K Sell
4,648
-118
-2% -$7.69K 0.14% 82
2021
Q1
$301K Sell
4,766
-5,333
-53% -$332K 0.14% 83
2020
Q4
$626K Buy
10,099
+3,554
+54% +$219K 0.31% 63
2020
Q3
$395K Buy
6,545
+1,669
+34% +$100K 0.22% 72
2020
Q2
$287K Buy
+4,876
New +$292K 0.17% 81
2020
Q1
– Sell
-3,485
Closed -$224K – 88
2019
Q4
$224K Buy
+3,485
New +$200K 0.13% 89
2018
Q3
– Sell
-5,198
Closed -$288K – 86
2018
Q2
$288K Buy
5,198
+34
+0.7% +$1.84K 0.23% 75
2018
Q1
$327K Buy
5,164
+26
+0.5% +$1.67K 0.27% 72
2017
Q4
$315K Buy
+5,138
New +$321K 0.26% 67

Other funds holding BMY

DeDora Capital's BMY Position: Q3 2026 in Review

DeDora Capital opened a new position in Bristol-Myers Squibb (BMY) in Q3 2026: 514 shares worth $32.1K. The stake represents 0.01% of the portfolio and ranks #212 among its holdings. This is a return to the name: DeDora Capital previously reported a position in BMY as recently as Q2 2023.

DeDora Capital first reported a position in BMY in Q4 2017 and has held it in 17 quarters since. The position peaked at $626K in Q4 2020. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • DeDora Capital held 514 shares of Bristol-Myers Squibb worth $32.1K as of Q3 2026.
  • Bristol-Myers Squibb was a new DeDora Capital position in Q3 2026.
  • Bristol-Myers Squibb made up 0.01% of DeDora Capital's portfolio in Q3 2026, its #212 holding.
  • DeDora Capital first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 17 quarters since.
  • DeDora Capital's Bristol-Myers Squibb position peaked at $626K in Q4 2020.
  • 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on DeDora Capital's 13F filing for Q3 2026, filed 26 Oct 2026.